Get the NavigAID SSc white paper

Biomarker research holds great promise for the identification of distinct SSc patient subgroups and the development of successful novel therapies.

In this white paper you will:

  • Discover the latest research developments that are set to revolutionize the way SSc is diagnosed and treated.
  • Learn about why taking a biomarker-driven approach to autoimmune disease drug development will help inform more effective treatment strategies

Simply fill out your details below to receive your download.

12 + 14 =

Copyright © 1997-2018
Protagen AGDortmund, Germany